We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Aqua British (AB) manufactures and sells premium English spring water in its patented 100% biodegradable water bottles. It asserts that millions of plastic bottles are ending up in landfills. AB aims to be at the forefront of the fight against plastic pollution, offering an alternative to PET, RPet, cartons and cans. It argues that its water bottles, caps and labels are made up of 100% sugarcane residues, are 100% recyclable and 100% compostable. AB also points out that its spring is fully equipped with solar panels to keep carbon emissions neutral. The company supplies water to renowned entities such as Hotel De Paris Monaco, Hotel InterContinental and South Kensington Club, West Ham United Women Football Club, Thermes Marins Monte Carlo, GreenBay Supermarket, and Compass Group Airbus France, amongst others. It will use 80% of the investment towards expanding its brand and distribution inside and outside of the UK, and 20% towards marketing and distribution channels.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £216,195
Perfino designs natural scent infused artisan jewellery. The company argues that one-third of humans are intolerant to synthetic chemicals and that up to 60% of these chemicals may be absorbed into the bloodstream. Perfino wants to change this scenario and provide fragrance lovers access to natural scents with no skin contact. Perfino pendants come with six super-absorbent lava stones and a bottle of expertly blended natural essential oils. Users need to simply add a drop to a stone, put it in the pendant, and enjoy a wonderful scent all day long. The company aims to disrupt the $310 billion global jewellery/perfume market with its products. Perfino's CEO has featured in the BBC’s CEO Secrets and Radio 4 Business Matters. The company will use the investment to grow its team and product range, boost sales and set up a membership service.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £74,268
Windsor & Eton Brewery (WAEB) is an award-winning Royal Warrant holding brewery. WAEB brews over 1.4 million pints each year and is on a mission to make beer Windsor's top attraction. WAEB has won over 70 national, international, and regional beer awards. It claims to be a supplier of exclusive bottled beers to the House of Commons, London’s Shakespeare’s Globe, and over 200 pubs, bars, and hotels. The company made over £600,000 of direct sales to consumers through its brewery tap, shop, and home deliveries in 2020. WAEB argues that it is running five successful bars in and near Windsor, serving nearly 7.6 million visitors per year. WAEB created the Windsor beer festival and is a member of the Worshipful Company of Brewers. They intend to use the investment to grow its estate from its existing five venues to twenty by 2026, start with a major new bar in the heart of Windsor, and buy a canning line on-site to ensure fresher beers for its customers.
days to go: Expired investment: £625,931
Taska is a fishing tackle brand that has been producing its own products since 2011. In 2017, it was acquired by LetsGetFishing LTD. Taska develops and designs its own products, and currently, it has over 400 products available. It aims to expand and launch its products into European markets by engaging with retailers/wholesalers via trade shows. It has built over 141,000 Facebook followers in the UK. Taska believes that it can replicate its social media success in the European market and organically grow sales through product savvy anglers. In the last 12 months, Taska had £1,000,000+ sales with a Net Profit of £9400.
days to go: Expired investment: £69,560
The Wild Curl (TWC) makes custom-formulated and plant-based curly hair products. The company chooses its ingredients based on research that centers around the composition of curly hair across different demographics. TWC argues that it supports and fights for inclusive beauty standards by empowering women to adopt their naturally curly hair since 65% of women in the world have textured hair. The company claims to have changed the hair journey of 5000 customers globally. TWC has 5,000 customers, 5,600 email contacts and 6,000 followers on social media. The company has earned £100,000 in revenue since its launch and shipped over 5,000 orders to customer’s doorsteps worldwide. TWC will use the investment to expand its product range focused on conditioners.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £95,689
BeneTalk is an innovative digital therapeutic solution, providing on-demand support to individuals who stutter and their families, aiming to enhance their quality of life and confidence. Stuttering affects millions globally, and with limited specialized therapy options, BeneTalk addresses accessibility challenges by offering timely assistance, aiming to mitigate the higher risk of low self-esteem and mental health issues faced by individuals who stutter and their families.
days to go: Expired investment: £173,123
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph